A formal definition, a brief history, and the principles that distinguish it from established pharmacology.
Endogenic pharmacology is the discipline within pharmacology concerned with modulating gene expression and cellular function from within the body's own regulatory architecture, rather than overriding the body's systems through external intervention.
It is distinguished from conventional (exogenic) pharmacology by its mechanism of working with rather than against the body's native regulatory pathways, and by its therapeutic compounds — known as bioregulators — which act through endogenous regulatory mechanisms rather than through receptor blockade, enzyme inhibition, or pathway override.
The canonical definition of the discipline, its mechanism of working with rather than against the body's native regulatory pathways, and the therapeutic compounds that act through endogenous mechanisms.
Read →How bioregulators interact with chromatin and gene-promoter regions, modulate peptide signaling networks, and restore endogenous regulatory peptide pools that decline with age, disease, or stress.
Read →The four founding principles established by the inventors and codified in the patent portfolio that anchors the field — endogenous regulation, gene expression instruction, the privileged short-peptide mechanism, and empirical discipline.
Read →How the two disciplines complement one another — exogenic for acute intervention, infection control, and pathway-specific blockade; endogenic for restorative regulation, age-associated decline, and chronic-condition management.
Read →